Eve Sleep Plc (EVE.L) Announced, in its trading update for the six months ended 30 June 2019, that the company made good progress in reducing EBITDA losses and improving cash management. In line with Board expectations, the underlying EBITDA loss reduced by 50% to £5.9 million from a loss of £11.9 million in H1 2018, driven by the refocus on just three markets, greater marketing efficiency and a reduction in overheads. Net cash at the end of the period was £12.5 million. Group revenue growth for the year is expected to be second half weighted. UK&I revenues for the period were broadly flat at 0.9% below last year, owing to the planned reduction in H1 marketing investment, as well as the challenging retail backdrop and a highly promotional mattress market. Separately, the company announced the appointment of finnCap Ltd as its Nominated Advisor and Corporate Broker with immediate effect.
RNS Number: 8736 F eve Sleep plc 17 July 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Andrew Hore Quoted #Micro 15 July 2019 #AFHP #HYDP #CFCP #COIN #ESO #KR1 #BEG #MED #TEK #AAU #IKA #MIRA #SOM #POLX #COS #EVE #WEN #FIH #CHAL #BVC #AIM #NEX #LSE #microcaps #smallcaps #stockstowatch #stocksinnews
Eve Sleep plc: Standard form for notification of major holdings.
I discuss i3 Energy #I3E Eve Sleep #EVE Catenae Innovation #CTEA and Bidstack #BIDS with Justin on the Vox Markets podcast. The interview starts at 20 minutes 26 seconds.
eve is a direct to consumer, e-commerce European sleep brand. Our aim is to design quality sleep products that are beautifully simple, and simply beautiful. Starting with the eve mattress we have expanded our range to 6 premium sleep products, now selling across 10 countries.
128 Albert Street